504 results on '"V. Gautier"'
Search Results
2. O2 Identification of a new factor involved in DNA methylation-mediated repression of latent HIV-1
- Author
-
S. Bouchat, R. Verdikt, N. Delacourt, C. Vanhulle, B. Van Driessche, G. Darcis, A. Pasternak, V. Avettand-Fenoel, C. Necsoi, V. Ledouce, M. Bendoumou, C. Schwartz, S. De Wit, A. Saez-Cirion, B. Berkhout, V. Gautier, C. Rouzioux, O. Rohr, and C. Van Lint
- Subjects
Microbiology ,QR1-502 ,Public aspects of medicine ,RA1-1270 - Published
- 2017
- Full Text
- View/download PDF
3. Growth Hormone and Insulin-like Growth Factor-1 in Children with Cholestatic Diseases and Pediatric Liver Transplantation
- Author
-
V. Gautier, Sergey, primary, P. Shevchenko, Olga, additional, M. Tsirulnikova, Olga, additional, M. Kurabekova, Rivada, additional, and E. Pashkova, Irina, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Treatment of chronic liver disease using cell‑engineered constructs: morphofunctional characteristics
- Author
-
M. Yu. Shagidulin, N. A. Onishchenko, A. V. Grechina, M. E. Krasheninnikov, A. O. Nikolskaya, E. A. Volkova, N. P. Mogeiko, N. A. Boiarinova, A. V. Lyundup, G. A. Piavchenko, L. I. Davydova, A. Yu. Arhipova, V. G. Bogush, and S. V. Gautier
- Subjects
regenerative medicine ,chronic liver disease treatment ,matrix ,microgel ,liver cells ,bone marrow-derived mesenchymal stem cells ,cell-engineered constructs ,Surgery ,RD1-811 - Abstract
Objective: to study the effectiveness of correcting the morphofunctional characteristics of the liver in an experimental model of chronic liver disease (CLD), using implanted cell-engineered constructs (CECs).Materials and methods. Experiments were carried out on male Wistar rats (n = 80) aged 6–8 months with an initial weight of 230–250 g. CLD was modeled by inoculating the rats with 60% CCl4 oil solution for 42 days based on a modified scheme. Microgel based on recombinant spidroin rS1/9 was used as a matrix for CECs fabrication. Allogeneic liver cells (LCs) and multipotent bone marrow-derived mesenchymal stem cells (BM-MSCs) from a healthy donor were used as the cellular component of the CECs. The effectiveness of the corrective effect of the implanted CECs was assessed in an experimental CLD model (n = 60) in two groups of rats: Group 1 (control, n = 20, 1 mL of saline solution was injected into the damaged liver parenchyma) and Group 2 (experimental, n = 40, CECs containing allogenic LCs and BM-MSCs in a 5 : 1 ratio in a volume of 1 mL were implanted into the damaged liver parenchyma). For long-term monitoring of the CEC state, the CECs were labeled by additional inclusion in Cytodex-3. The effectiveness of the regulatory effect of CECs on regenerative processes in the liver was evaluated using biochemical, morphological and morphometric techniques, as well as by flow cytometry at 90 days after implantation.Results. In the control group, the mortality rate in CLD was 25%. There was no death in the experimental group with CLD after CEC implantation. The CECs were found to have a corrective effect on the biochemical and morphological parameters of the liver in CLD during 90 days of follow-up, with concomitant preservation of structural cellular homeostasis in the implanted CECs. Conclusion. Implantation of CECs in the liver facilitates effective correction of CLD by activating regenerative processes in the damaged liver, which is due to long-term preservation of structural cellular homeostasis in the CECs.
- Published
- 2022
- Full Text
- View/download PDF
5. Risks and ways of preventing kidney dysfunction in drug-induced immunosuppression in solid organ recipients
- Author
-
Sh. R. Galeev and S. V. Gautier
- Subjects
organ transplantation ,induction therapy ,immunosuppressive therapy ,adverse events ,renal failure ,Surgery ,RD1-811 - Abstract
Immunosuppressive therapy (IMT) is the cornerstone of treatment after transplantation. The goal of immunosuppression is to prevent acute and chronic rejection while maximizing patient survival and long-term graft function. However, the expected effects of IMT must be balanced against the major adverse effects of these drugs and their toxicity. The purpose of this review is to summarize world experience on current immunosuppressive strategies and to assess their effects on renal function.
- Published
- 2022
- Full Text
- View/download PDF
6. Risk factors in deceased donor liver transplantation: a single centre experience
- Author
-
S. I. Zubenko, A. R. Monakhov, M. A. Boldyrev, V. R. Salimov, A. D. Smolianinova, and S. V. Gautier
- Subjects
liver transplantation ,deceased donor ,expanded criteria donor ,risk factors ,Surgery ,RD1-811 - Abstract
Deceased brain-dead donor liver transplantation (LT) is a high-risk intervention. The outcome depends on a large number of modifiable and non-modifiable factors. Objective: to analyze our own experience and identify preoperative and perioperative prognostic factors for poor outcomes in LT. Materials and methods. The study included 301 liver transplants performed between January 2016 and December 2021. Donor and recipient characteristics, intraoperative data, perioperative characteristics including laboratory test data, and the nature and frequency of complications were used for the analysis. Results. The 1-, 3- and 5-year recipient survival rates were 91.8%, 85.1%, and 77.9%, respectively; graft survival rates were 90.4%, 83.7%, and 76.7%, respectively. The most significant predictors of poor outcome of LT on the recipient side were biliary stents (HR 7.203, p < 0.01), acutely decompensated cirrhosis (HR 2.52, p = 0.02); in the postoperative period, non-surgical infectious complications (HR 4.592, p < 0.01) and number of reoperations (HR 4.063, p < 0.01). Donor creatinine level (HR 1.004, p = 0.01, one factor analysis; HR 1.004, p = 0.016, multivariate analysis) was the only reliable prognostic negative factor. Conclusion. LT taking into account established risk factors will improve surgery outcomes and help personalize the therapy for each patient.
- Published
- 2022
- Full Text
- View/download PDF
7. Organ donation and transplantation in the Russian Federation in 2021. 14th Report from the Registry of the Russian Transplant Society
- Author
-
S. V. Gautier and S. M. Khomyakov
- Subjects
organ donation ,kidney, liver, heart, lung transplantation ,transplant center ,waiting list ,registry ,covid-19 ,shumakov national medical research center of transplantology and artificial organs ,Surgery ,RD1-811 - Abstract
Objective: to monitor the current trends and developments in organ donation and transplantation in the Russian Federation based on data from the year 2021. Materials and methods. Heads of organ transplant centers were surveyed through questionnaires. Data control was done using the information accounting system of the Russian Ministry of Health. We performed a comparative analysis of data obtained over years from various federal subjects of the Russian Federation and transplantation centers. Results. Based on data retrieved from the 2021 Registry, 45 kidney, 29 liver and 17 heart transplantation programs were existing in the Russian Federation as of the year 2021. The kidney transplant waiting list in 2021 included about 10.5% of the 60,000 patients receiving dialysis. Organ donation activity in 2021 was 4.5 per million population, with a 78.4% multi-organ procurement rate and an average of 3.0 organs procured from one effective donor. In 2021, there were 9.5 kidney transplants per million population, 4.2 liver transplants per million population and 2.0 heart transplants per million population. Same year, the number of transplant surgeries performed in the Russian Federation increased by 18.3% compared to the year 2020, reaching the level of 2019. In Moscow, organ donation activity was 23.7 per million population, that of 2019. In 2021, the city of Moscow and the Moscow region accounted for 12 functioning organ transplant centers, performing 57.7% of all kidney transplants and 70.5% of all extrarenal transplants in the country. The number of organ recipients in the Russian Federation has exceeded 140 per million population. Conclusion. In 2021, donor activity and volume of transplant care in Russian regions recovered. This was after the decline in 2020 that resulted from the new coronavirus disease (COVID-19) pandemic. In addition, 7 new transplant programs were established. Further development of regional organ donation and transplantation programs, improvement in their efficiency, increase in the activity of transplant centers and development of inter-regional collaboration are expected in the Russian Federation in 2022.
- Published
- 2022
- Full Text
- View/download PDF
8. Heart transplantation for primary cardiac sarcoma
- Author
-
A. Yu. Goncharova, N. N. Koloskova, V. N. Poptsov, V. M. Zakharevich, N. P. Mojeiko, А. R. Zakiryanov, N. N. Sayfullina, K. S. Kiryakov, and S. V. Gautier
- Subjects
heart transplantation ,primary cardiac sarcoma ,immunosuppressive therapy ,Surgery ,RD1-811 - Abstract
Primary cardiac sarcoma is a rapidly progressive, aggressive cardiac tumor that is very rare in the general population. Conservative treatment for this tumor is not very effective. The only effective treatment is radical surgical removal of the malignancy. However, if sarcoma removal cannot be performed, heart transplantation (HT) becomes the only treatment option. The median survival of heart recipients with preoperative cardiac sarcoma is 8.5 months. Globally, such operations are performed in a small number of cases. This paper presents the first experience of HT for a patient with primary cardiac sarcoma in the Russian Federation.
- Published
- 2022
- Full Text
- View/download PDF
9. Normothermic ex vivo perfusion of isolated lungs in an experiment using a russian-made perfusion system
- Author
-
S. V. Gautier, O. M. Tsirulnikova, I. V. Pashkov, D. O. Oleshkevich, I. A. Filatov, V. K. Bogdanov, D. M. Bondarenko, N. P. Mozheiko, A. A. Karpov, N. S. Bunenkov, and N. V. Grudinin
- Subjects
lung transplantation ,donation ,ex-vivo perfusion ,Surgery ,RD1-811 - Abstract
According to global health statistics, respiratory diseases, together with infectious complications and hereditary lung diseases, rank as the third leading cause of death. Today, lung transplantation (LTx) is a well-recognized modality of treatment for end-stage chronic lung disease. However, the number of LTx surgeries performed is much lower than other solid organs. This is due to the high requirements for the potential donor and characteristics of the lung graft, reflecting the efficiency of gas exchange function. Non-compliance with the selection criteria leads to deselection of donors, which, according to various estimates, occurs in 80–85% of cases. One of the ways to increase the number of lung transplant surgeries is to restore them to the level of optimal gas exchange parameters, which can be achieved and objectively assessed during normothermic ex vivo lung perfusion (EVLP). EVLP is becoming increasingly common at leading transplantation centers in Europe and North America. This has significantly increased the number of transplant surgeries as a result of using lungs procured from suboptimal donors and rehabilitated via EVLP. In our pilot study, the developed Russian-made mechanical circulatory support system showed that performing normothermic EVLP for isolated lungs under experimental conditions is feasible. Basic and optimized perfusion protocols have fully shown that they are reliable and efficient.
- Published
- 2022
- Full Text
- View/download PDF
10. Ways of improving the legal regulation of human organ and tissue transplantation in the Russian Federation
- Author
-
E. V. Karakulina, S. M. Khomyakov, O. A. Aleksandrova, I. V. Lysikov, S. V. Shedenko, and S. V. Gautier
- Subjects
organ donation ,organ transplantation ,tissue transplantation ,donation and transplantation law ,donation and transplantation procedure ,donation and transplantation licensing ,medical personnel ,nomenclature of medical specialties ,nomenclature of medical services ,professional standards of specialist physicians ,organ and tissue transplantation ,surgery ,transplant team ,Surgery ,RD1-811 - Abstract
Over the past 10 years, significant breakthroughs have been achieved in Russian transplantology in the field of regulatory legal framework. During this period, the powers of government authorities in the field of healthcare on organization of transplant care and organ donation have been defined, and sources and mechanisms for target financing of medical activities related to organ donation for transplantation purposes have been identified. The procedure for providing medical care under surgery (human organ and/or tissue transplantation) has been adopted, and a state registry system for donor organs, donors and recipients has been created. Measures on organ donation and transplantation in the Russian Federation have been approved within the «Healthcare Development», a framework of the state program of the Russian Federation. The Shumakov National Medical Research Center of Transplantology and Artificial Organs (Shumakov Center) has also been identified as the core institution that coordinates the activities of the entire transplant industry in the Russian Federation. Transplant medical care is currently being provided by specialist physicians trained in human organ and tissue transplantation, in collaboration with other specialist physicians. The Nomenclature of Specialties of Specialists with Higher Medical and Pharmaceutical Education, approved by the Russian Ministry of Health via Order No. 700n of October 7, 2015, does not contain a separate specialty related to human organ and tissue transplantation activities, and this is quite justified. However, in order to improve the legal regulation of transplantation activities, it is necessary to unify the requirements for specialists providing medical care in human organ/tissue transplantation. This can be achieved by developing uniform approaches to the definition of labor functions in the professional standards of specialist doctors involved in transplantation.
- Published
- 2022
- Full Text
- View/download PDF
11. Renal replacement therapy in heart transplant recipients
- Author
-
I. L. Poz, A. G. Strokov, Yu. V. Kopylova, V. N. Poptsov, and S. V. Gautier
- Subjects
heart transplantation ,acute kidney injury ,hemodialysis ,kidney transplant after heart transplant ,Surgery ,RD1-811 - Abstract
Kidney injury in cardiac transplant recipients is one of the most severe complications affecting both short- and long-term transplant outcomes. The need for renal replacement therapy (RRT) is determined not only and not so much by the degree of renal dysfunction, as by the need for correction of fluid balance and metabolic disorders. These circumstances are associated with the specificity of extracorporeal renal replacement therapy in donor heart recipients. In this review, we discuss the problems of early versus delayed initiation of RRT, anticoagulation and vascular access, advantages and disadvantages of continuous and intermittent techniques. Special attention is paid to chronic kidney injury and peculiarities of kidney transplantation in heart recipients.
- Published
- 2022
- Full Text
- View/download PDF
12. Evaluation of the efficacy of a novel perfusion solution for normothermic ex vivo lung perfusion compared with Steen solution™ (animal experimental study)
- Author
-
S. V. Gautier, O. M. Tsirulnikova, I. V. Pashkov, N. V. Grudinin, D. O. Oleshkevich, D. M. Bondarenko, N. P. Моzheikо, A. A. Karpov, and N. S. Bunenkov
- Subjects
lung transplantation ,donation ,ex vivo lung perfusion ,Surgery ,RD1-811 - Abstract
Respiratory diseases, together with infectious complications and hereditary lung diseases, rank third in international mortality statistics. Today, lung transplantation is a recognized method of treating end-stage lung diseases. However, the number of transplant surgeries performed is not much. This is down to the high requirements on the condition of a potential lung donor and directly on the quality of the donor lung. This has significantly limited the number of optimal donors. Rehabilitation of donor lungs to optimal gas exchange indicators can be achieved and objectively assessed in the course of ex vivo lung perfusion (EVLP). The EVLP procedure is widespread in leading transplantation centers in Europe and North America. It allows to significantly expand the pool of donor lungs, thereby serving a greater number of patients in need of lung transplantation. The possibility of EVLP procedure using publicly available perfusion equipment was demonstrated. The optimized protocol fully demonstrated its reliability and efficiency. The developed perfusion solution had no statistically significant differences in comparison with the Steen SolutionTM, which in the future will serve as an alternative for EVLP procedure.
- Published
- 2021
- Full Text
- View/download PDF
13. Organ donation and transplantation in the Russian Federation in 2020 13th Report from the Registry of the Russian Transplant Society
- Author
-
S. V. Gautier and S. M. Khomyakov
- Subjects
organ donation ,kidney ,liver ,heart ,lung ,pancreas transplantation ,transplant center ,waiting list ,registry ,covid-19 ,Surgery ,RD1-811 - Abstract
Objective: to monitor the current trends and developments in organ donation and transplantation in the Russian Federation based on the 2020 data.Materials and methods. Heads of organ transplant centers were surveyed through questionnaires. Data control was done using the information accounting system of the Russian Ministry of Health. Between separate federal subjects of the Russian Federation and between transplantation centers, comparative analysis of data obtained over years was performed.Results. Based on data retrieved from the 2020 Registry, 44 kidney, 29 liver and 16 heart transplantation programs were functioning in the Russian Federation in 2020. The kidney transplant waitlist in 2020 included about 11.5% of the total 60,000 patients receiving dialysis. Organ donation activity in 2020 was 3.9 per million population, with a 74.6% multi-organ procurement rate and an average of 2.9 organs being procured from one effective donor. In 2020, there were 7.7 kidney transplants per million population, 3.8 liver transplants per million population and 1.7 heart transplants per million population. Same year, the number of transplant surgeries performed in the Russian Federation fell by 19.2% to 13.4 per million population against the background of the outbreak caused by the new coronavirus disease COVID-19. The city of Moscow and the Moscow region in 2020 accounted for 13 out of the 14 functioning organ transplantation centers, performing 66.3% of all kidney transplants and 72.4% of all extrarenal transplants in the country. The number of organ recipients in the Russian Federation have exceeded 130 per million population.Conclusion. In 2020, despite the new coronavirus disease COVID-19 pandemic and accompanying restrictive measures, transplant centers continued to perform organ transplants, run a waiting list and monitor organ recipients. However, the number of effective donors (–22.9%) and organ transplants (–19.2%) decreased, tentatively to the 2017 levels. In 2021, transplant centers with support from health authorities will have to restore the volume of transplant care with consideration to the real needs of the population and the donor resource. The COVID-19 factor, including vaccination of the population, as well as financial support to transplantation programs, will be decisive in shaping the trend of transplantation care and organ donation in the federal subjects of the Russian Federation in the coming 1–2 years.
- Published
- 2021
- Full Text
- View/download PDF
14. Pathogenetic mechanisms, epidemiology and classification of acute kidney injury in heart transplant recipients
- Author
-
I. L. Poz, A. G. Strokov, V. N. Poptsov, A. O. Shevchenko, and S. V. Gautier
- Subjects
cardiorenal syndrome ,heart transplantation ,epidemiology ,criteria for acute kidney injury ,Surgery ,RD1-811 - Abstract
Kidney injury in heart transplant recipients is of a complex nature and bears the features of all types of cardiorenal interaction impairment. Pre-transplant renal dysfunction, perioperative acute kidney injury, as well as factors associated with graft and immunosuppression, determine the prevalence and severity of kidney pathology in this group of patients. This review examines the pathophysiology of kidney dysfunction in heart failure, the epidemiology, and criteria for acute kidney injury.
- Published
- 2021
- Full Text
- View/download PDF
15. Bronchial complications after lung transplantation
- Author
-
I. V. Pashkov, M. T. Bekov, and S. V. Gautier
- Subjects
lung transplantation ,bronchial arteries ,anastomotic dehiscence ,bronchial stenosis ,bronchomalacia ,bronchial stenting ,interventional bronchology ,Surgery ,RD1-811 - Abstract
Bronchial complications are among the main causes of impairing postoperative period and thansplant failure. Severe bronchial complications are very rare but have a high mortality rate. Light forms decrease transplant function and while progressing can leads to life-threatening conditions without required treatment. Nowadays there is a huge necessity in classification of diagnostic and bronchial complications treatment on different terms after lung transplantation. Methods of observation bronchoscopy and interventional bronchology are allowing us to realize prevention, diagnostic and treatment bronchial complications.
- Published
- 2021
- Full Text
- View/download PDF
16. Clinical transplantology in the Russian Federation: from innovative phenomenology to accessible medical care
- Author
-
S. V. Gautier
- Subjects
Surgery ,RD1-811 - Published
- 2022
17. Review of surgical techniques for performing laparoscopic donor hepatectomy
- Author
-
K. O. Semash and S. V. Gautier
- Subjects
liver transplantation ,living donation ,laparoscopic liver resection ,Surgery ,RD1-811 - Abstract
Living related liver transplantation has proved to be an effective, safe and radical method for treating end-stage liver diseases. In the last decade, a laparoscopic approach to donor hepatectomy has been gradually introduced into clinical practice. According to world literature, there are presently no uniform standards for performing laparoscopic liver resections in living donors. This literature review considers almost all methods for performing this surgery in living donors. These methods are described in transplant centers around the world.
- Published
- 2021
- Full Text
- View/download PDF
18. Successful treatment of vanishing bronchus intermedius syndrome following lung transplantation
- Author
-
I. V. Pashkov, M. T. Bekov, R. A. Latypov, D. O. Oleshkevich, E. F. Shigaev, E. V. Lebedev, K. S. Smirnov, and S. V. Gautier
- Subjects
lung transplantation ,cystic fibrosis ,bronchial stenosis ,vanishing bronchus intermedius syndrome ,Surgery ,RD1-811 - Abstract
The vanishing bronchus intermedius syndrome is a type of peripheral bronchial stenosis that develops in lung recipients within two to nine months after transplantation. Lack of timely diagnosis and effective treatment leads to increased mortality and poor quality of life. The clinical case presented demonstrates the successful long-term treatment of vanishing bronchus intermedius syndrome in a lung recipient using interventional bronchoscopy.
- Published
- 2021
- Full Text
- View/download PDF
19. The role of endovascular and endobiliary methods in the treatment of post-liver transplant complications
- Author
-
S. V. Gautier, M. A. Voskanov, A. R. Monakhov, and K. O. Semash
- Subjects
liver transplantation ,endovascular treatment ,endobiliary treatment ,hepatic artery stenosis ,hepatic artery thrombosis ,portal vein stenosis ,biliodigestive strictures ,Surgery ,RD1-811 - Abstract
Liver transplantation is the treatment of choice for patients with end-stage liver disease or acute liver failure. However, vascular complications, such as hepatic artery stenosis and/or thrombosis, graft portal vein stenosis and biliodigestive strictures following liver transplantation are still common despite improvements and innovations in surgical techniques. These complications can lead to graft damage or even death, and they are caused by many factors. Although minimally invasive interventional radiology is an optional treatment for such post-liver transplant complications, there is little research on this method of treatment.
- Published
- 2021
- Full Text
- View/download PDF
20. Functional efficiency of cell-engineered liver constructs based on tissue-specific matrix (experimental model of chronic liver failure)
- Author
-
M. Yu. Shagidulin, N. A. Onishchenko, Yu. B. Basok, A. M. Grigoriev, A. D. Kirillova, E. A. Nemets, E. A. Volkova, I. M. Iljinsky, N. P. Mozheiko, V. I. Sevastianov, and S. V. Gautier
- Subjects
liver ,liver failure ,regeneration ,cell-engineered constructs ,bioartificial organs ,matrixes ,Surgery ,RD1-811 - Abstract
Objective: to investigate the functional efficiency of a cell-engineered construct (CEC) of the liver based on tissuespecific matrix consisting of decellularized rat liver fragments, allogeneic liver cells and multipotent mesenchymal stromal cells (MSCs) isolated from the bone marrow on an experimental model of chronic liver failure (CLF).Materials and methods. In creating liver CECs, the liver for decellularization and liver cells were obtained from male Wistar rats. MSCs were isolated from rat bone marrow. The functional efficacy of CEC was investigated on an experimental CLF model obtained by priming rats with CCl4 solution. At different periods after implantation, the outcomes were assessed based on the biochemical parameters of cytolysis. Morphological changes in the liver were analyzed by histochemical methods in the control (administration of saline solution into the liver parenchyma) and experimental (administration of liver CEC into the liver parenchyma) groups. Results. It was shown that implantation of the proposed CEC normalizes blood biochemical parameters and structural disorders of the damaged rat liver faster (by day 30 after introduction of CEC instead of day 180 in the control). The CEC was also shown to have reduced animal mortality from 50 to 0%, which is due to early activation of proliferation of viable liver cells and faster formation of new blood vessels. These effects are down to either stimulation of the internal regenerative potential of the damaged liver during CEC implantation or long-term functioning of the transplanted cells as part of the CEC based on the decellularized liver matrix. Conclusion. The liver CEC, implanted into the liver parenchyma in laboratory animals with a CLF model, has a functional activity.
- Published
- 2021
- Full Text
- View/download PDF
21. COVID-19 in solid organ transplant recipients: initial report from national multicenter observational study «ROKKOR-recipient»
- Author
-
S. V. Gautier, A. O. Shevchenko, O. M. Tsirulnikova, S. M. Khomyakov, O. N. Kotenko, V. E. Vinogradov, I. N. Abyzov, G. D. Avetisyan, A. Yu. Anisimov, L. Yu. Artyukhina, M. T. Bekov, V. A. Berdinsky, V. S. Bogdanov, A. Yu. Bykov, A. Yu. Vinokurov, A. Yu. Goncharova, D. P. Evdokimov, D. V. Ezersky, V. E. Zagainov, V. M. Zakharevich, K. N. Zelenin, E. S. Ivanova, A. A. Kartashev, N. G. Kvadratova, I. G. Kim, N. N. Koloskova, V. L. Korobka, I. R. Kurbanuglov, M. A. Lysenko, I. A. Miloserdov, Ya. G. Moisyuk, G. V. Nikolaev, I. V. Ostrovskaya, N. Yu. Petrova, A. V. Petryaev, A. V. Pinchuk, V. S. Platonov, V. N. Poptsov, Z. A. Porchkhidze, D. A. Saydulaev, A. D. Sapozhnikov, S. B. Semchenko, M. M. Skorobogatov, V. Yu. Tereshchenko, N. F. Frolova, D. V. Khalikova, and T. A. Khalilulin
- Subjects
organ transplantation ,pandemic ,covid-19 ,sars-cov-2 ,risk factors ,russian transplant ,Surgery ,RD1-811 - Abstract
We herein present our initial report from «ROKKOR-recipient», a national multicenter observational study. The prevalence, risk factors, clinical manifestations and outcomes of the novel coronavirus disease 2019 (COVID-19) in solid organ transplant recipients receiving immunosuppressive therapy were investigated. The study enrolled 251 COVID-19 patients (220 kidney recipients, 7 liver recipients, 1 liver-kidney recipient, and 23 heart recipients). The subjects came from 20 regions in Russia. The symptoms, clinical presentation, imaging and lab test results, therapy and outcomes of COVID-19 were described. It was established that solid organ transplant recipients with COVID-19 have a higher risk of developing adverse events. Predictors of adverse events include associated cardiovascular diseases, pulmonary diseases, diabetes, and kidney failure. Symptoms of the disease include dyspnea, rash and catarrhal signs, as well as initial low blood oxygen saturation (SpO2 10 × 109/L), elevated creatinine levels (>130 μmol/L) and a marked decrease in glomerular filtration rate, requiring hemodialysis. Performing organ transplant surgery in COVID-19 does not increase the risk of adverse events but could save the lives of waitlisted terminally ill patients.
- Published
- 2020
- Full Text
- View/download PDF
22. Efficacy of albumin dialysis as a bridge to transplantation in children with end-stage liver disease
- Author
-
A. G. Strokov, I. L. Poz, A. R. Monakhov, S. V. Meshcheryakov, M. A. Voskanov, and S. V. Gautier
- Subjects
cirrhosis ,liver failure ,albumin dialysis ,liver transplantation ,pediatric liver transplantation ,extracorporeal liver support ,hepatic encephalopathy ,fractionated plasma separation and adsorption ,Surgery ,RD1-811 - Abstract
Liver transplantation is the only effective treatment modality for end-stage liver disease. However, donor organs are not always available. In some cases, the gravity of the patient’s condition makes transplantation impossible. In this regard, the use of artificial liver support systems helps in preparing a patient for transplant surgery. Objective: to conduct a retrospective study aimed at evaluating the efficiency of fractionated plasma separation and adsorption system. Materials and methods. From January 2019 to May 2020, 139 pediatric liver transplants were. We analyzed the data of 5 pediatric patients (2 girls and 3 boys, aged 12 to 17 years) who received fractionated plasma separation and adsorption (FPSA) sessions as a bridge to transplantation. The main clinical indication for FPSA was severe hepatic encephalopathy (grade 3 according to the West Haven Criteria), which was observed at 350–872 μmol/L (average 597 ± 98 μmol/L) serum bilirubin level. The FPSA sessions were conducted on a Prometheus device using AV-600 hemofilters as dialyzers (Fresenius Medical Care, Germany). Results. Depending on the extent of bilirubinemia in patients, it took from one (in one case) to three (in one case) daily FPSA sessions to restore clear consciousness, appetite and physical activity. Average bilirubin levels after treatment cycles decreased from 597 ± 98 to 236 ± 73 μmol/L. All patients successfully underwent liver transplant surgery within two to five days, two patients received a liver fragment from a living related donor. Conclusion. The FPSA system stabilizes the condition of potential recipients with acute liver failure. Further research is required to develop optimal regimens for albumin dialysis.
- Published
- 2020
- Full Text
- View/download PDF
23. Treatment of biliodigestive anastomotic strictures after transplantation of left lateral segment of the liver
- Author
-
A. R. Monakhov, B. L. Mironkov, M. A. Voskanov, S. V. Meshcheryakov, E. T. Azoev, K. O. Semash, T. A. Dzhanbekov, O. V. Silina, and S. V. Gautier
- Subjects
transplantation of the left lateral segment of the liver ,long-term transplant outcomes ,complications ,biliary strictures ,correction ,Surgery ,RD1-811 - Abstract
Many studies have shown that biliary complications after transplantation of the left lateral segment (LLS) of the liver reduce graft and recipient survival. Thus, timely correction of biliary complications, and strictures in particular, improves long-term outcomes in transplantation. Objective: to analyze our own experience in correcting biliary strictures in LLS graft transplantation. Materials and methods. From February 2014 to April 2020, 425 LLS grafts were transplanted in children. 19 (4.5%) patients were diagnosed with biliary strictures at different times after transplantation (from 0.2 to 97 months). Results. Biliary strictures were more often formed a year after transplantation (17.8 ± 23.9 months). In 14 out of the 19 patients, internal-external biliary drainage was successfully performed with phased replacement of the catheter with one that was larger in diameter (from 8.5 Fr to 14 Fr). The catheters were removed in 8 patients after completion of the treatment cycle. Restenosis was not observed during follow-up (13 ± 8.7 months) after the internal-external biliary drainage catheter had been removed. In 5 cases, antegrade passage of a guide wire through the stricture was unsuccessful. As a result, biliary reconstruction was performed in 4 (21.1%) patients and retransplantation was required in 1 (5.3%) patient. Conclusion. An antegrade minimally invasive approach can successfully eliminate biliary strictures in most children after liver LLS graft transplantation. The proposed technique is effective and safe.
- Published
- 2020
- Full Text
- View/download PDF
24. Recent history of transplantology: 35 years of heart transplantation and 25 years of living related liver transplantation in the Russian Federation
- Author
-
S. V. Gautier
- Subjects
Surgery ,RD1-811 - Published
- 2022
25. Advances in machine perfusion of isolated donor organs
- Author
-
S. V. Gautier
- Subjects
Surgery ,RD1-811 - Published
- 2022
26. Investigation on eggshell apex abnormality (EAA) syndrome in France: isolation of Mycoplasma synoviae is frequently associated with Mycoplasma pullorum
- Author
-
M. Cisneros-Tamayo, I. Kempf, J. Coton, V. Michel, S. Bougeard, C. de Boisséson, P. Lucas, M.-H. Bäyon-Auboyer, G. Chiron, C. Mindus, and A. V. Gautier-Bouchardon
- Subjects
Mycoplasma synoviae ,Eggshell apex abnormalities ,Layers ,MALDI-TOF ,Mycoplasma pullorum ,Veterinary medicine ,SF600-1100 - Abstract
Abstract Background Mycoplasma synoviae (MS) is known to cause Eggshell Apex Abnormality (EAA) syndrome characterized by an altered shell surface with increased translucency on the apex. However, no large-scale studies have been conducted to obtain prevalence data of EAA and MS isolates associated to this syndrome. This manuscript reports the results of two field studies performed in the French poultry industry (2015–2017): focusing mainly on investigation of presence and prevalence of EAA in different types of laying hen flocks (phase 1), and isolation of MS strains from EAA-infected flocks (phase 2). Results The first survey included 77 farms of commercial layers in three French egg-production regions, hosting 40 flocks in alternative systems (ALT) and 56 in furnished cages (FC). Seven flocks (4 FC and 3 ALT) presented EAA clinical signs, giving a prevalence of 7.3% in this studied sample. A second independent field study was conducted to identify MS by in vitro cultivation and PCR in samples from 28 flocks with clinical signs of EAA. Different types of biological specimens were collected in EAA-affected flocks and submitted to the laboratory. M. synoviae was detected in 25/28 flocks, from both production systems (5/5 ALT and 20/23 FC). Detection of MS was significantly higher in tracheal swabs (59%) than in cloacal (10.5%), albumen (3.6%) and egg yolk (1.1%) swabs. It is worth to mention that attempts to clone MS from positive samples were often hampered by the presence of another Mycoplasma species, which showed fast growing behaviour in the selective media used in this study (Frey Medium 4 and Frey Medium 4 supplemented with erythromycin). The use of MALDI-TOF mass spectrometry in combination with next-generation sequencing (NGS) results allowed the identification of this fast growing mycoplasma as Mycoplasma pullorum, which was detected in 14 of the 25 (56%) MS-positive flocks. Conclusions These results confirmed the presence of the EAA syndrome in MS-positive flocks of layers in France, reared in different regions and in different production systems (ALT and FC). Studies need to be conducted to test whether M. pullorum may influence the expression of clinical signs of EAA in MS-infected layer farms.
- Published
- 2020
- Full Text
- View/download PDF
27. Guidelines on improving health care quality in transplantation services in the federal subjects of Russia
- Author
-
S. V. Gautier and S. M. Khomyakov
- Subjects
organ donation ,organ transplantation ,schumakov center of transplantology ,transplant register ,transplant recommendations ,Surgery ,RD1-811 - Abstract
Objective: to provide guidelines on how to improve the quality of health care in transplantation services for Russian regions; the recommendations were prepared by the Shumakov National Medical Research Center of Transplantology and Artificial Organs (Shumakov Center) based on field trips made by Shumakov Center from 2018 to 2019 in order to assess the status and development prospects of organ donation and organ transplantation in various regions of the Russian Federation. Materials and methods. Based on the over 40 field trips made by the Center, analytical reports, as well as recommendations were prepared by the Ministry of Health of Russia for regional health authorities and transplant centers. Guidelines were selected from these recommendations to address the most significant and common gaps and errors inherent in organ donation and organ transplantation in the regions. On the basis of the analytical reports, guidelines for the roadmap (plan) for organ donation and transplantation in the region were prepared. Results. A methodological framework for solving a wide range of managerial challenges on organ donation and organ transplantation is proposed for heads and experts at healthcare institutions and medical organizations. Conclusion. Organ donation and organ transplantation should be developed for the regions using the roadmap (plan) prepared and approved by the regional health authority. This approach brings stability and consistency to the development process, creates a resource base for development, and provides coordination and oversight.
- Published
- 2020
- Full Text
- View/download PDF
28. Organ donation and transplantation in the Russian Federation in 2019. 12th report from the Registry of the Russian Transplant Society
- Author
-
S. V. Gautier and S. M. Khomyakov
- Subjects
organ donation ,kidney ,liver ,heart ,lung ,pancreas transplantation ,transplant center ,waitlist ,registry ,Surgery ,RD1-811 - Abstract
Objective: to monitor current trends and developments in organ donation and transplantation in the Russian Federation based on the 2019 data. Materials and methods. Heads of organ transplant centers were surveyed. Data obtained over years from federal subjects of the Russian Federation and from organ transplant centers in the country were analyzed and compared. Results. Based on data retrieved from the 2019 Registry, only 46 kidney, 31 liver and 17 heart transplant centers were functioning in Russia. In 2019, there were 6,878 potential recipients in the kidney transplant waitlist. This represents 13.7% of the 50,000 dialysis patients in the country. Donation activity in 2019 reached 5.0 per million population; multi-organ procurement rate was 71.6%; 2.9 organs on average were procured from one effective donor. In 2019, there were 10.0 kidney transplants per million population, 4.0 liver transplants per million population and 2.3 heart transplants per million people. Same year, the number of transplant surgeries performed in Russia rose 10.7% from the previous year. Moscow and Moscow Oblast alone have 13 functioning organ transplantation centers. They account for half of all kidney transplant surgeries and 70% of all liver and heart transplants performed in the country. Organ recipients in the Russian Federation have exceeded 16,000 in number. Conclusion. Organ transplantations in Russia keep on increasing – 10–15% per year. Donor and transplant programs are also becoming more effective and efficient. However, the demand for organ transplants far exceeds the current supply of available organs in the Russian Federation. Peculiarities of the development of organ donation and organ transplantation in Russia in 2019 were associated with some factors, such as structure and geographical location of transplant centers, waitlisting of patients, funding sources and amount, and management of donor and transplant programs. The national transplantation registry will be developed taking into account new monitoring and analysis challenges.
- Published
- 2020
- Full Text
- View/download PDF
29. Comparative analysis of induction immunosuppressive therapy protocols in renal transplant recipients (retrospective review)
- Author
-
Sh. R. Galeev, R. Kh. Galeev, M. I. Khasanova, and S. V. Gautier
- Subjects
kidney transplantation ,recipient survival ,immunosuppressive protocols ,double induction immunosuppressive therapy ,Surgery ,RD1-811 - Abstract
Objective: to evaluate the clinical efficacy and outcomes of kidney transplants performed using an alternative immunosuppressive therapy protocol that is based on double induction. Materials and methods. We examined 296 cases of kidney transplants performed in 295 patients between January 1, 2004 and December 31, 2018. Based on induction immunosuppressive therapy regimen, the patients were divided into two groups. Group 1 included patients who underwent transplantation from January 1, 2004 to June 30, 2013 and who used the standard induction immunosuppression protocol. Group 2 included patients who did transplant surgeries between the period January 7, 2013 and December 31, 2018 and who received the “double” induction protocol being analyzed. The method of dividing patients into these groups is associated with routine implementation of the analyzed protocol at the transplantation center since July 1, 2013. Results. Graft and recipient survival rates at all follow-up periods were higher in the group of patients who received the “double” induction immunosuppressive protocol than in the standard group. The studied protocol provides initially better and more stable graft function than in standard therapy. This is especially valuable in centers experiencing difficulties in assessing pre-transplant immunological risk. The graft and recipient survival rates achieved by the analyzed protocol are more pronounced in deceaseddonor kidney transplantation. Conclusion. Positive results obtained from retrospective analysis of the protocol under study justify a prospective randomized study.
- Published
- 2020
- Full Text
- View/download PDF
30. Organ donation and transplantation in the Russian Federation in 2018. 11th report of the Registry of the Russian Transplant Society
- Author
-
S. V. Gautier and S. M. Khomyakov
- Subjects
organ donation ,kidney ,liver ,heart ,lung ,pancreas transplantation ,transplant center ,waiting list ,registry ,Surgery ,RD1-811 - Abstract
Aim: to monitor current trends and developments in organ donation and transplantation in the Russian Federation based on the 2018 data.Materials and methods. Heads of organ transplant centers were surveyed. Data obtained over years from constituent entities of the Russian Federation (also called regions) and from organ transplant centers located in these regions was analyzed and compared.Results. According to data retrieved from the 2018 National Registry, only 49 kidney, 28 liver and 18 heart transplant centers were functional in Russia. As of the end of 2018, there were about 6,219 people on the kidney transplant waiting list. This is about 13.8% of the total number of the 45,000 patients receiving dialysis. Donation rate in 2018 was 4.3 donors per million population, while multi-organ procurement level stood at 67.3%. An average of 2.9 organs were procured from one effective donor. In 2018, there were 9.3 kidney transplants, 3.4 liver transplants and 1.9 heart transplants per million population. In the same year, the number of transplants performed in Russia in creased by 12.3% from the year 2017. In Moscow and Moscow Oblast alone, there are 15 functioning organ transplantation centers. These centers perform half of all kidney transplants and 70% of all liver and heart transplants in the country. The number of organ transplant recipients in Russia is approaching 16,000.Conclusion. Russia continues to witness a long-term trend of growing number of organ transplants – 10–15% per year. The geographical presence or organ transplant centers continues to expand. The number of transplant centers and their activity is increasing. Donor programs are becoming more effective and efficient. Extrarenal transplantation technologies are being deployed in Russian regions. The number of patients on the national waiting list for organ transplantation is increasing, while their mortality is decreasing. The number of patients with transplanted organs is increasing. Shortages in donor organs in Russia is still down to human causes – poor organization. The number of organ transplants in Russian regions depends on government funding. The quality and safety of transplant programs rely on the transplant activity of centers. In order to achieve the clinical and economic benefits of organ transplantation as a treatment method, monitoring and follow-up after transplant will be required.
- Published
- 2019
- Full Text
- View/download PDF
31. Prevention and surgical treatment of urological complications in kidney transplant recipient
- Author
-
D. A. Saydulaev, I. A. Miloserdov, and S. V. Gautier
- Subjects
urological complications ,kidney transplantation ,Surgery ,RD1-811 - Abstract
Post-kidney transplant urological complications (failure of a newly formed anastomosis, obstructive uropathy, necrosis of graft ureter, graft ureteral stricture, development of vesicoureteral reflux in the renal graft, recurrent urinary infection) are one of the main causes of graft loss and various deaths. This literature review aims at analyzing world studies on prevention methods (routine graft ureteric stenting) and surgical techniques for treating urological complications (laparoscopic correction of supravesical urinary tract obstruction in a graft kidney) in kidney recipients.
- Published
- 2019
- Full Text
- View/download PDF
32. Decellularization of Human Pancreatic Fragments with Pronounced Signs of Structural Changes
- Author
-
Victor I. Sevastianov, Anna S. Ponomareva, Natalia V. Baranova, Lyudmila A. Kirsanova, Yulia B. Basok, Evgeniy A. Nemets, Dmitry N. Kruglov, Igor A. Miloserdov, and Sergey V. Gautier
- Subjects
pancreas ,extracellular matrix ,decellularization ,tissue-specific scaffold ,human adipose derived stem cell ,pancreatic islets ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
A significant lack of donor organs restricts the opportunity to obtain tissue-specific scaffolds for tissue-engineering technologies. One of the acceptable solutions is the development of decellularization protocols for a human donor pancreas unsuitable for transplantation. A protocol of obtaining a biocompatible tissue-specific scaffold from decellularized fragments with pronounced human pancreas lipomatosis signs with preserved basic fibrillary proteins of a pancreatic tissue extracellular matrix was developed. The scaffold supports the adhesion and proliferation of human adipose derived stem cell (hADSCs) and prolongs the viability and insulin-producing function of pancreatic islets. Experiments conducted allow for the reliance on the prospects of using the donor pancreas unsuitable for transplantation in the technologies of tissue engineering and regenerative medicine, including the development of a tissue equivalent of a pancreas.
- Published
- 2022
- Full Text
- View/download PDF
33. Our 2022 priorities: consolidating the transplant community. Et multa alia…
- Author
-
S. V. Gautier
- Subjects
Surgery ,RD1-811 - Published
- 2022
34. Assessment of the quality of life of organ reoipients based on the results of the First Russian transplant games
- Author
-
T. Yu. Shelekhova, E. E. Achkasov, I. A. Lazareva, Yu. A. Krumkacheva, A. A. Sungatulina, and S. V. Gautier
- Subjects
Transplantation ,Immunology and Allergy - Abstract
Objective: to evaluate the role of physical activity (at sports games) in improving the quality of life of organ recipients.Materials and methods. We examined 42 adult lung, heart, kidney and liver recipients, and patients undergoing renal replacement therapy (mean age 42.6 ± 12.09 years) - participants of the First Russian Transplant Games. The results were analyzed. Quality of life of the recipients was assessed using the nonspecific SF-36 questionnaire.Results. After solid organ transplantation, the interviewed recipients answered that they try to lead an active lifestyle, to engage in accessible physical activities, and to participate in sports events intended for organ recipients. Assessment of the quality of life according to the SF-36 questionnaire showed that all the participants had high scores in terms of the physical and psychological component, which is associated with regular physical training and sports. Conclusion. Physical exercise and active participation in sports activities are an important component in the socialization and rehabilitation of organ recipients. These two factors also improve the psychological and physical components of the quality of life of the recipients.
- Published
- 2023
35. Correlative Fluorescent Scanning Probe Nanotomography Used to Study the Intracellular Distribution of Doxorubicin in MCF-7 Human Breast Adenocarcinoma Cells
- Author
-
O. I. Agapova, A. E. Efimov, K. E. Mochalov, D. O. Solovyeva, A. M. Gileva, E. A. Markvicheva, D. V. Yakovlev, A. V. Lyundup, V. A. Oleinikov, I. I. Agapov, and S. V. Gautier
- Subjects
General Immunology and Microbiology ,General Medicine ,General Agricultural and Biological Sciences ,General Biochemistry, Genetics and Molecular Biology - Published
- 2023
36. Two years of COVID-19: transplant care in the Russian Federation 2021
- Author
-
S. V. Gautier
- Subjects
Surgery ,RD1-811 - Published
- 2022
37. Heart transplantation as a radical method of restoring the quality of life in recipients with end-stage heart failure
- Author
-
S. V. Gautier, V. M. Zacharevich, T. A. Khalilulin, A. О. Shevchenko, V. N. Poptsov, R. L. Ahmadzai, A. M. Goltz, A. R. Zakiryanov, N. N. Koloskova, N. Y. Zacharevich, E. А. Nikitina, O. A. Pozdnyakov, and K. S. Kiryakov
- Subjects
heart transplantation ,quality of life ,sf-36 ,rehabilitation after heart transplantation ,physical activity ,psycho-emotional indicators of quality of life ,Surgery ,RD1-811 - Abstract
Aim: the aim of the study was a comparative assessment of the quality of life of recipients with donor heart at the stages before and after heart transplantation.Materials and methods: the study included 150 patients who underwent orthotopic heart transplantation at the «Academician V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs», Ministry of Health of the Russian Federation from January 2009 to March 2018.Results. Analysis of the research results indicates extremely low rates of both physical activity and overall health assessment at the pre-transplantation stage. During the first month after heart transplantation, the role of functioning due to physical condition (p = 0.02), general health (p = 0.001), mental health (p = 0.01) and vital activity (p = 0.01) significantly increase. Tolerance to physical activity increases by 201.26% during the first month after the heart transplantation (p = 0.02). The most complete indicators of quality of life are restored after one year of operation: physical functioning (p = 0.00007), role-based functioning due to physical condition (p = 0.00006), pain threshold (p = 0.04), general health (p = 0.00007), mental health (p = 0.0001), role functioning due to the emotional state (p = 0.01), social functioning (p = 0.0001), vital activity (p = 0.000032). High rates of quality of life are maintained for periods longer than 5 years after transplantation. The best indicators of quality of life in recipients of transplanted heart are observed a year after surgery and manifest a significant increase in all indicators. A comparative analysis of the results obtained in the preoperative period and a year after the operation of orthotopic heart transplantation indicates a significant improvement in the quality of life of patients.Conclusion. The results of the study showed that during the year after heart transplantation in patients with terminal heart failure, there was a significant improvement in all indicators characterizing the quality of life. High levels of physical, mental and social activity achieved by the first year are maintained for at least 5 years, which indicates the high efficiency of orthotopic heart transplantation as a radical method of treating severe heart failure.
- Published
- 2019
- Full Text
- View/download PDF
38. Early postoperative complications after lung transplantation
- Author
-
I. V. Pashkov, V. N. Poptsov, D. O. Oleshkevich, and S. V. Gautier
- Subjects
lung transplantation ,post transplant complications ,Surgery ,RD1-811 - Abstract
Lung transplantation is the final treatment option for end-stage lung disease when all possible conservative treatment is exhausted. According to the International Society for Heart and Lung transplantation Registry, more than 60000 lung transplantations have been performed worldwide. The early post-transplant period following lung transplantation remains critical because of numerous complications. These complications can be divided into several groups. These are surgical complications, primary graft dysfunction and acute rejection, infection, cardiovascular, abdominal and renal disorder. This complications may result in significant morbidity, mortality and limit short and long-term survival. The aim of this review is to describe the main postoperative complications in first month after lung transplantation in the world practice.
- Published
- 2019
- Full Text
- View/download PDF
39. Surgical Aspects of Split Liver Transplantation: а Review
- Author
-
S. V. Gautier, R. A. Latypov, and A. R. Monakhov
- Subjects
split liver transplantation ,left lateral section ,extended right lobe ,deceased donor ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Aim. To analyse the surgical aspects of performing a split liver transplantation in patients with end-stage liver disease.Key findings. Split liver transplantation (SLT) is a technique allowing two functional grafts to be obtained from one deceased donor to simultaneously save the lives of two recipients. The global clinical experience of SLT application currently comprises more than three decades. Criteria necessary for successful SLT were developed, based both on assessment of graft quality (age and anthropometric characteristics of the donor, laboratory parameters, ultrasound data, length of stay in intensive care, as well as macroscopic intraoperative assessment of the liver), and on the selection of recipients (primarily in accordance with the height-weight characteristics and the use of the GRWR [graftto-recipient weight ratio]). The use of these criteria allows the results to be achieved comparable to other types of liver transplantation (a whole liver from a deceased donor or liver fragments of an intravital donor). However, issues involved with of the optimal choice of surgical techniques remain to be solved, which include such key aspects as the anatomical method of separation (left lateral section and extended right lobe; anatomical left and right lobes of the liver), an optimal method of separation (ex situ or in situ) and others. The issues of logistics of the SLT application, including the principles of allocation of transplants, also remain significant. Ethical aspects are equally important, since, theoretically, the widespread introduction of the SLT technique may increase the risk of graft loss. The immediate and long-term SLT results require further study, which makes it possible to form a more objective opinion on the effectiveness of the technique.Conclusion. SLT shows good results both in the near and in the remote period. The key aspects of SLT performing are a deep understanding of the variant anatomy of the liver and a high level of knowledge of liver resection surgery. The active use of SLT allows the pool of donor organs to be increased, which is of great importance under the conditions of their permanent lack.
- Published
- 2019
- Full Text
- View/download PDF
40. The influence of the ratio of liver cells and bone marrow in the implantable cell-engineering structures of the liver on the recovery efficiency of functional and morphological parameters in chronic liver failure
- Author
-
M. Yu. Shagidulin, N. A. Onishchenko, M. E. Krasheninnikov, A. O. Nikolskaya, E. A. Volkova, I. M. Iljinsky, N. P. Mogeiko, V. I. Sevastianov, and S. V. Gautier
- Subjects
liver ,liver failure ,regeneration ,cell transplantation ,cell-engineering construction ,bioartificial organs ,biodegradable matrices ,Surgery ,RD1-811 - Abstract
Aim: to determinate the most effective liver cells and multipotent mesenchymal stromal cells of bone marrow (MMSC BM) ratio into implantable cell engineering constructions (CECs) used for chronic liver failure (CLF) correcting.Materials and methods. For creating liver CECs it was used a biopolymer implant – a composition of a heterogeneous collagen-containing gel (BMCG) (Sphero®GEL trademark) containing viable liver cells and MMSC BM in the following ratios – 1 : 1; 5 : 1 and 10 : 1 respectively. CECs with different ratios of liver cells and MMSC BM were implanted into liver of rats in which chronic liver failure (CLF), was modeled by using CCl4. The effectiveness of the regulatory effects of CECs (with different cell ratios) on regenerative processes in livers were assessed by using biochemical, morphological and morphometric methods at different periods after their implantation.Results. Corrective effect of CECs with different cell composition on biochemical and morphological parameters of livers at chronic liver failure was established. During studying the liver CECs with various cell ratios of liver cells and MMSC BM (1 : 1; 5 : 1 and 10 : 1 respectively), it was found that the most optimal ratio of cells into the CECs is 5 : 1, because at this ratio of cells, there were a more distinct normalization of the morphological and functional liver parameters within 365 days after modeling CLF and maintenance of the structural homeostasis into the CECs. Themselves, which allows predicting their long-term regulatory effect on the liver tissue in CLF and maintaining its normal structural and functional state.Conclusion. The effective correction of chronic liver failure can be carried out by using the implanted liver CECs, in which donor liver cells and MMSC BM where presented in ratios – 1 : 1; 5 : 1 and 10 : 1. But analysis of prolonged correction of liver morphological and functional parameters at CECs using it was allow to recommend the preferences using of CECs with ratio 5 : 1, because prolonged preservation of structural homeostasis into these CECs makes possible to prognosticate their prolonged regulatory action on the liver tissue at CLF, especially for recipients on a waiting list for liver transplantation.
- Published
- 2019
- Full Text
- View/download PDF
41. Heart transplantation waiting list of V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs. Trends from 2010 to 2017
- Author
-
S. V. Gautier, V. N. Poptsov, N. N. Koloskova, V. M. Zakharevich, A. О. Shevchenko, I. I. Muminov, E. A. Nikitina, V. S. Kvan, T. A. Halilulin, А. R. Zakiryanov, and А. М. Golts
- Subjects
critical heart failure ,heart transplantation ,waitlist ,Surgery ,RD1-811 - Abstract
The aim: to analyze the waiting list for heart transplantation from 2010 to 2017 and to characterize recipients with chronic heart failure III–IV NYHA Class.Methods. The study comprised 997 patients (139 [14%] females and 858 [86%] males) included in the waiting list for heart transplantation the period from January 2010 to December 2017. The average age of patients on the waiting list was 49.0 ± 12.0 (from 10 to 78 years). Before making a decision on inclusion in the waiting list, all patients underwent clinical and instrumental examination, including general clinical studies, echocardiography, measurement of central hemodynamic parameters using a Swan–Gans catheter, computer and/or magnetic resonance imaging of the chest, abdominal and brain.Results. Heart transplantation was performed on 728 patients (99 females – 13.6% and 629 males – 86.4%) including 18 children aged 12 to 17 years (14.18 ± 2.07 years). Mortality in the waiting list in 2010 was 16.1%, compared with 3.2% in 2017.
- Published
- 2019
- Full Text
- View/download PDF
42. Lung transplantation for idiopathic pulmonary arterial hypertension: perioperational features
- Author
-
V. N. Poptsov, E. A. Spirina, I. V. Pashkov, A. V. Belikova, D. O. Oleshkevich, R. A. Latipov, O. M. Tsirulnikova, A. C. Epremian, E. F. Shigaev, and S. V. Gautier
- Subjects
lung transplantation ,idiopathic pulmonary arterial hypertension ,Surgery ,RD1-811 - Abstract
Lung transplantation (LT) for idiopathic pulmonary arterial hypertension (IPAH) now is the only radical treatment of this disease.Aim: to analyze own experience of performing LT in patients with IPAH.Materials and methods. 8 adult IPAH patients, who underwent LT between 2014 and october 2018, were included. In 7 of 8 patients undergoing bilateral lung transplantation on intraoperative venoarterial extracorporeal membrane oxygenation (VA ECMO) with prolongation into the postoperative period.Results. VA ECMO support was prolonged into postoperative period 6 and 7 days respectively in 2 (25,0%) patients and 3 days in 6 (75,0%) patients. Hospital mortality in IPAH patients was 1.Conclusions. Own experience demonstrates that LT is an effective method of treatment in patients with IPAH. Hospital, 1- and 3-year survival rates for the patient collective were 87.5, 75.0 and 75.0% respectively.
- Published
- 2019
- Full Text
- View/download PDF
43. 5th National Congress of Transplant Surgeons featuring international participants
- Author
-
S. V. Gautier
- Subjects
Surgery ,RD1-811 - Published
- 2021
44. Transplantology and artificial organs in the new nomenclature of scientific specialties: a harmonious combination of stability and renewal
- Author
-
S. V. Gautier
- Subjects
Surgery ,RD1-811 - Published
- 2021
45. 2021: a new reality and conventional priorities
- Author
-
S. V. Gautier
- Subjects
Surgery ,RD1-811 - Abstract
As we present the first issue of the Journal in 2021, we would like, as always, to outline our plans and perspectives for the coming year.
- Published
- 2021
46. Decellularization of cartilage microparticles: Effects of temperature, supercritical carbon dioxide and ultrasound on biochemical, mechanical, and biological properties
- Author
-
Victor I. Sevastianov, Yulia B. Basok, Alexey M. Grigoriev, Evgeny A. Nemets, Alexandra D. Kirillova, Liudmila A. Kirsanova, Aleksey E. Lazhko, Anastasia Subbot, Marina V. Kravchik, Yusef D. Khesuani, Elizaveta V. Koudan, and Sergey V. Gautier
- Subjects
Biomaterials ,Metals and Alloys ,Biomedical Engineering ,Ceramics and Composites - Abstract
One of the approaches to restoring the structure of damaged cartilage tissue is an intra-articular injection of tissue-engineered medical products (TEMPs) consisting of biocompatible matrices loaded with cells. The most interesting are the absorbable matrices from decellularized tissues, provided that the cellular material is completely removed from them with the maximum possible preservation of the structure and composition of the natural extracellular matrix. The present study investigated the mechanical, biochemical, and biological properties of decellularized porcine cartilage microparticles (DCMps) obtained by techniques, differing only in physical treatments, such as freeze-thaw cycling (Protocol 1), supercritical carbon dioxide fluid (Protocol 2) and ultrasound (Protocol 3). Full tissue decellularization was achieved, as confirmed by the histological analysis and DNA quantification, though all the resultant DCMps had reduced glycosaminoglycans (GAGs) and collagen. The elastic modulus of all DCMp samples was also significantly reduced. Most notably, DCMps prepared with Protocol 3 significantly outperformed other samples in viability and the chondroinduction of the human adipose-derived stem cells (hADSCs), with a higher GAG production per DNA content. A positive ECM staining for type II collagen was also detected only in cartilage-like structures based on ultrasound-treated DCMps. The biocompatibility of a xenogenic DCMps obtained with Protocol 3 has been confirmed for a 6-month implantation in the thigh muscle tissue of mature rats (n = 18). Overall, the results showed that the porcine cartilage microparticles decellularized by a combination of detergents, ultrasound and DNase could be a promising source of scaffolds for TEMPs for cartilage reconstruction.
- Published
- 2022
47. A Round-Table Discussion
- Author
-
M. Sh. Khubutia, S. V. Gautier, M. A. Paltsev, A. G. Chuchalin, S. L. Dzemeshkevich, A. V. Chzhao, M. G. Minina, G. Sganga, S. U. Astanina, Ya. G. Moisyuk, and M. M. Kaabak
- Subjects
Medicine - Abstract
A Round-Table Discussion.
- Published
- 2018
- Full Text
- View/download PDF
48. A current status of transplantation in the Russian Federation
- Author
-
S. V. Gautier
- Subjects
Medicine - Abstract
A current status of transplantation in the Russian Federation.
- Published
- 2018
- Full Text
- View/download PDF
49. ORGAN DONATION AND TRANSPLANTATION IN RUSSIAN FEDERATION IN 2017 10TH REPORT OF THE NATIONAL REGISTRY
- Author
-
S. V. Gautier and S. M. Khomyakov
- Subjects
organ donation ,kidney transplantation ,liver transplantation ,heart transplantation ,lung transplantation ,pancreas transplantation ,transplant center ,waiting list ,register ,Surgery ,RD1-811 - Abstract
Aim. To analyse the status and trends in the development of organ donation and organ transplantation in the Russian Federation according to 2017 data.Materials and methods. The survey of heads of transplantation centers was conducted. A comparative analysis of the data obtained in the dynamics of years, between individual subjects of the Russian Federation, the centers of transplantation is performed.Results. According to the register in 2017 in Russia there were only 41 centers for kidney transplantation, 24 liver and 16 hearts. The waiting list for kidney transplantation in 2017 included 5,531 potential recipients, which is approximately 13.8% of the total number of 40,000 patients receiving dialysis. The level of donor activity in 2017 was 3.8 per million of the population, while the share of multiorgan seizures was 66.5%, the average number of organs received from one effective donor was 2.8. In 2017, the level of kidney transplantation was 8.0 per million of the population, the liver transplantation index was 3.0 per million of the population; the rate of heart transplantation is 1.7 per million of the population. In 2017 the number of transplants in Russia increased by 11.3% compared to 2016. There are 11 transplantation centers on the territory of Moscow and the Moscow Region, and half of all kidney transplants and 70% of all liver and heart transplantations are performed. The number of patients with transplanted organs in the Russian Federation is approaching 13,000.Conclusion. In the Russian Federation there is a strong tendency to increase the number of effective donors and to increase the number of organ transplants, and the number of transplant centers is also increasing. In recent years, the country has created prerequisites for the development of organ donation and transplantation: the regulatory and legal framework, public donation funding, material and technical base, etc. In the coming years, positive experience and organizational patterns of organ donation and transplantation from successful regions in Other subjects of the Russian Federation for building effective programs. The leading role in this process should be played by the Academician V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs.
- Published
- 2018
- Full Text
- View/download PDF
50. THE PROBLEMS AND THE OPTIMIZATION OF NON-PULSATING PUMPS OF THE ASSISTED BLOOD CIRCULATION
- Author
-
G. P. Itkin and S. V. Gautier
- Subjects
mechanical support of circulation ,terminal heart failure ,rotary pumps ,modulation of output fl ow ,control system ,Surgery ,RD1-811 - Abstract
The method of mechanical circulation support using non-pulsating fl ow pumps, built on the principle of rotary (centrifugal and axial) pumps, took the leading direction (94%) in the world clinical practice for the treatment of the patients with terminal heart failure. Despite this, the clinic application of these pumps in a number of cases faced with the numbers of negative problems associated with this technology. This is stimulated of a new direction of principles for a control of the rotary pumps, based on the modulation of the speed pumps. The article analyzes the negative factors of the clinical application of non-pulsating fl ow pumps and gives an overview of the methods the optimization of the control pump based on the modulation of the output fl ow.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.